These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15028409)
1. Re: Cancers of the head and neck region in developing countries. Radiother Oncol. 2003 Apr;67(1):1-2. Gupta T; Laskar SG Radiother Oncol; 2004 Feb; 70(2):207-8; author reply 208-9. PubMed ID: 15028409 [No Abstract] [Full Text] [Related]
2. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134 [TBL] [Abstract][Full Text] [Related]
3. Value of postoperative radiotherapy in patients with pathologic N1 neck disease. Jäckel MC; Ambrosch P; Christiansen H; Martin A; Steiner W Head Neck; 2008 Jul; 30(7):875-82. PubMed ID: 18302275 [TBL] [Abstract][Full Text] [Related]
4. Head and neck squamous cell carcinoma: the role of post-operative adjuvant radiotherapy. Dinshaw KA; Agarwal JP; Laskar SG; Gupta T; Shrivastava SK; Cruz AD J Surg Oncol; 2005 Jul; 91(1):48-55. PubMed ID: 15999358 [TBL] [Abstract][Full Text] [Related]
5. Head and neck cancer among lifelong never-smokers and ever-smokers: matched-pair analysis of outcomes after radiation therapy. Chen AM; Chen LM; Vaughan A; Farwell DG; Luu Q; Purdy JA; Vijayakumar S Am J Clin Oncol; 2011 Jun; 34(3):270-5. PubMed ID: 20622648 [TBL] [Abstract][Full Text] [Related]
6. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360 [TBL] [Abstract][Full Text] [Related]
7. In regards to: Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous cell carcinoma of the head and neck by Pradier et al. (Int J Radiat Oncol Biol Phys 2005;63:1368-1377). Cengiz M; Ozyar E; Genc M Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):955; author reply 955-6. PubMed ID: 16751078 [No Abstract] [Full Text] [Related]
8. [Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice]. Horiot JC; Bontemps P; Begg AC; Le Fur R; Van den Bogaert W; Bolla M; N'Guyen T; Van den Weijngaert D; Bernier J; Lusinchi A; Stuschke D; Lopez Torrecilla D; Jancar B; Collette L; Van Glabbeke M; Pierart M Bull Cancer Radiother; 1996; 83(4):314-20. PubMed ID: 9081333 [No Abstract] [Full Text] [Related]
9. Hyperfractionated accelerated radiochemotherapy (HFA-RCT) with mitomycin C for advanced head and neck cancer. Widder J; Dobrowsky W; Schmid R; Pokrajac B; Selzer E; Pötter R Radiother Oncol; 2004 Nov; 73(2):173-7. PubMed ID: 15542164 [TBL] [Abstract][Full Text] [Related]
10. Current trends of surgical management of head and neck carcinomas. Bauer AM Nurs Clin North Am; 2001 Sep; 36(3):501-6, x. PubMed ID: 11532664 [TBL] [Abstract][Full Text] [Related]
11. External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy. León X; López M; Piñeiro Z; Langendijk JA; Leemans CR; Quer M Head Neck; 2007 Sep; 29(9):815-21. PubMed ID: 17405168 [TBL] [Abstract][Full Text] [Related]
12. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy? Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229 [TBL] [Abstract][Full Text] [Related]
13. [Current trends in head and neck squamous cell carcinomas]. Lacau Saint-Guily J; Périé S Bull Cancer; 2006 Jan; 93(1):51-9. PubMed ID: 16455506 [TBL] [Abstract][Full Text] [Related]
15. [Microsatellite molecular analysis of the resection margins and laterocervical lymph nodes in the planning of complementary postoperative radiotherapy in early squamous carcinoma (stage I and II) of the head and neck]. Gallo O Acta Otorhinolaryngol Ital; 2000 Dec; 20(6):383-5. PubMed ID: 11398673 [No Abstract] [Full Text] [Related]
16. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Oddone N; Morgan GJ; Palme CE; Perera L; Shannon J; Wong E; Gebski V; Veness MJ Cancer; 2009 May; 115(9):1883-91. PubMed ID: 19224549 [TBL] [Abstract][Full Text] [Related]
17. Staging of head and neck cancer. Ennis RD; Knisely JP; Wilson LD N Engl J Med; 1995 Jun; 332(26):1787-8; author reply 1789-90. PubMed ID: 7619166 [No Abstract] [Full Text] [Related]
18. Treatment results on advanced neck metastasis (N3) from head and neck squamous carcinoma. Carvalho AL; Kowalski LP; Agra IM; Pontes E; Campos OD; Pellizzon AC Otolaryngol Head Neck Surg; 2005 Jun; 132(6):862-8. PubMed ID: 15944556 [TBL] [Abstract][Full Text] [Related]
19. Is there a new role for induction chemotherapy in the treatment of head and neck cancer? Forastiere AA J Natl Cancer Inst; 2004 Nov; 96(22):1647-9. PubMed ID: 15547172 [No Abstract] [Full Text] [Related]
20. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck. Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]